CI

At a glance

ClinicalIndex Comparison Record
Phase 3Recruiting· 524 target
Drug / intervention
Multiple cardiovascular drugs related to "Golden Triangle"drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04980716
NCT04980716Phase 3RecruitingMonitorUpdated 7mo ago · Completion was 4mo ago
Slow Enrollment
Long Recruiting
Monitor

Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients Who Receiving Radical Concurrent Chemoradiotherapy and Immunotherapy: a Prospective, Randomized Controlled, Multicenter Phase III Clinical Trial.

Sun Yat-sen University·interventional·Posted Jul 28, 2021·Updated Nov 18, 2025

In Brief

A Phase 3 clinical trial evaluating Multiple cardiovascular drugs related to "Golden Triangle" for Non-small Cell Lung Cancer and Cardiovascular Complication. Currently recruiting, targeting 524 participants across 1 site.

Signals

Enrolling slower than its timeline implies

Detailed Summary

This is a prospective, randomized, controlled, multi-center phase III clinical trial that intends to evaluate the role of early cardiovascular intervention based on impedance cardiography in patients with locally advanced non-small cell lung cancer receiving radical radiochemotherapy±immunotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 3RecruitingOverdue
20222023202420252026
First PostedJul 28, 2021
Enrollment StartJun 1, 2021
Primary CompletionJan 31, 2026
Study CompletionJul 1, 2026
TodayJul 1, 2026
Enrollment to primary: 4.7 yearsPosted 4.9 years ago

Interventions

Multiple cardiovascular drugs related to "Golden Triangle"drug

Based on impedance cardiography results at each timepoints, cardiovascular drug treatment and exercise plan will be given in the intervention group.